VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF) today
announced that it will begin an observational study on the use of cannabinoids
as therapy for chronic pain. A group of well-known pain specialists will lead
the study, taking place in Melbourne, Australia, which expects to provide
long-term (24 month) data in order to evaluate the efficacy of medical cannabis
in treating pain and further support development of VIVO’s portfolio of medical
cannabis products. VIVO is funding the effort in the form of a research grant
to its partner in the study, Australian Medical Cannabis Service (“AMCS”).
“Driven by unmet clinical needs, medical cannabis products and treatment plans
continue to gain momentum in Australia,” VIVO Chief Executive Officer Barry
Fishman said in the news release. “The Study will help to inform VIVO’s product
development through data gathered from both patients and physicians. This access
to primary data is expected to continue to ensure our products address the
specific health and wellness needs of our clients and customers, something that
we believe provides distinct advantage. We remain committed to ensuring
Australians have access to our medical cannabis, and to our efforts to change
the way people view cannabis.”
To view the full press release, visit http://ibn.fm/uuPMu
About VIVO Cannabis(TM)
VIVO Cannabis(TM), based in Napanee, Ontario, is recognized
for trusted, high-quality products and services. It holds production and sales
licenses from Health Canada and operates world-class indoor cultivation
facilities with proprietary plant-growing technology. VIVO has a collection of
premium brands targeting unique customer segments, including Beacon
Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO
acquired Canna Farms, a premium cannabis company based in Hope, British
Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years
of craft cultivation experience and expertise, as well as a significant patient
base and positive cash flow. The Company is significantly expanding its
production capacity and pursuing partnership and product development opportunities
domestically, as well as in select international markets, including Germany and
Australia. VIVO also operates Harvest Medicine, a patient-centric and highly
scalable network of specialty medical cannabis clinics as well as a free
telemedicine app. VIVO has a healthy balance sheet and is well-positioned to
accelerate its growth in Canada and internationally. For more information,
visit the company’s website at www.VivoCannabis.com.
NOTE TO INVESTORS: The latest news and updates
relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment